Studien

IMMUTACE A Phase II single-arm, open-label study of transarterial chemoembolization (TACE) in combination with nivolumab performed for intermediate stage hepatocellular carcinoma (HCC) AIO-HEP-0217 · Rekrutierung beendet Studie anzeigen

IMMUCHEC A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC) AIO-HEP-0117 · Rekrutierung beendet Studie anzeigen

DURATION Durvalumab (MEDI4736) in frail and elder patients with metastatic NSCLC AIO-YMO/TRK-0416 · Rekrutierung beendet Studie anzeigen

FORCE Fostering efficacy of anti – PD-1 – treatment: Nivolumab plus radiotherapy in advanced NSCLC AIO-YMO/TRK-0415 · Rekrutierung beendet Studie anzeigen

MEDISARC A randomized phase II study of Durvalumab (MEDI4736) and Tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma. AIO-STS-0415 · Rekrutierung beendet Studie anzeigen

PREPARE A phase III study testing the role of PRoactivE coaching on PAtient REported outcome in advanced or metastatic renal cell carcinoma treated with sunitinib or a combination of pembrolizumab + axitinib or avelumab + axitinib in first line therapy AIO-NZK-0115ass · Studie beendet Studie anzeigen

AVETUX Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer – The phase II AVETUX-CRC trial. AIO-KRK-0216 · Studie beendet Studie anzeigen

AIO-KRK-0214 mFOLFOX6 vs. mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial AIO-KRK-0214 · Rekrutierung beendet Studie anzeigen

NALIRICC A randomized phase II trial of Nal-Iri and 5-Fluorouracil compared to 5-Fluorouracil in patients with cholangio- and gallbladder carcinoma in second-line therapy AIO-HEP-0116 · Rekrutierung beendet Studie anzeigen

PRIMUS Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) (PRIMUS) AIO-TRK-0115 · Studie beendet Studie anzeigen